Enovis (ENOV) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
Annual meeting scheduled for May 19, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials online or request copies before voting.
Voting matters and shareholder proposals
Election of ten directors is proposed, with all nominees recommended for approval.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) is included.
Amendment to the 2020 Omnibus Incentive Plan is up for approval.
Proxies are authorized to vote on other business as may arise at the meeting.
Board of directors and corporate governance
Ten director nominees are listed for election, reflecting board continuity and governance focus.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Enovis
- Q2 2026 saw 5% organic growth, margin gains, strong cash flow, and reaffirmed guidance.ENOV
Q2 2026 - Double-digit growth, tech innovation, and ASC expansion drive strong outlook for 2026.ENOV
2026 CG Musculoskeletal Conference - All director nominees and proposals were approved by majority, with no stakeholder questions.ENOV
AGM 2026 - Q1 2026 sales up 5%, margins and EPS improved, guidance reaffirmed amid macro headwinds.ENOV
Q1 2026 - Board recommends all proposals, emphasizing governance, pay-for-performance, and ESG focus.ENOV
Proxy filing - 2025 saw robust sales growth, margin gains, and innovation, with 2026 guidance targeting further improvements.ENOV
Q4 2025 - Lima integration and new product launches drive growth, margin expansion, and innovation in 2025.ENOV
CG 2025 Musculoskeletal Conference - Q1 2025 sales up 8% with margin gains; revenue outlook raised, EBITDA trimmed on tariffs.ENOV
Q1 2025 - 6%-6.5% organic growth and margin expansion expected in 2025, driven by innovation and integration.ENOV
43rd Annual J.P. Morgan Healthcare Conference 2025